GLP-1 medications slow gastric emptying, decrease hunger hormones, and help regulate blood sugar—all of which result in reduced cravings and lower calorie intake. This often leads to significant and sometimes rapid weight loss. However, without intentional movement or resistance training, the body can lose muscle along with fat.

Women facing hormonal imbalances from menopause, PCOS (Polycystic Ovary Syndrome), or endometriosis often find themselves struggling with stubborn weight gain, fatigue, insulin resistance, and increased inflammation. Traditional diets and exercise sometimes aren't enough—and that’s where GLP-1 medications like semaglutide (Ozempic®, Wegovy®) and tirzepatide (Mounjaro®, Zepbound™) come into play. Originally designed for diabetes management, these medications are now showing powerful benefits for women managing hormone-related conditions.

Microdosing on a GLP-1 medication means starting with a lower dose and gradually increasing over time to allow your body to adjust more gently. This approach can minimize common side effects like nausea while still helping to control appetite and support steady, sustainable weight loss. It’s also a great option for maintaining your results long-term—many clients continue on a low dose after reaching their goal weight to help prevent rebound weight gain and stay on track.

Weight loss isn’t just about willpower—it’s about biology. If you’ve ever felt like your body fights you every step of the way, you’re not alone. GLP-1 medications like semaglutide and tirzepatide are changing the game by working with your body’s natural systems to support sustainable weight loss.